PeptideDB

Epinephrine bitartrate 51-42-3

Epinephrine bitartrate 51-42-3

CAS No.: 51-42-3

Epinephrine bitartrate (Adrenalinium; L-Adrenaline, l-Epinephrine, (-)-Adrenaline acid, (-)-Adrenaline), the bitartrate
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Epinephrine bitartrate (Adrenalinium; L-Adrenaline, l-Epinephrine, (-)-Adrenaline acid, (-)-Adrenaline), the bitartrate salt of epinenphrine which is the active sympathomimetic hormone from the adrenal medulla, is an alpha- and beta-adrenergic receptor stimulator. It causes gastrointestinal relaxation and vasoconstriction, stimulates the heart, dilates bronchi and cerebral vessels, and activates the alpha- and beta-adrenergic systems. It is used to postpone the absorption of local anesthetics and to treat asthma and heart failure.



Physicochemical Properties


Molecular Formula C13H19NO9
Molecular Weight 333.29
Exact Mass 333.105
Elemental Analysis C, 46.85; H, 5.75; N, 4.20; O, 43.20
CAS # 51-42-3
Related CAS #
51-42-3
PubChem CID 5815
Appearance Solid powder
Boiling Point 413.1ºC at 760 mmHg
Melting Point ~155 °C (dec.)
Flash Point 207.9ºC
Index of Refraction -16.5 ° (C=2, H2O)
Hydrogen Bond Donor Count 8
Hydrogen Bond Acceptor Count 10
Rotatable Bond Count 6
Heavy Atom Count 23
Complexity 288
Defined Atom Stereocenter Count 3
SMILES

O([H])[C@@]([H])(C([H])([H])N([H])C([H])([H])[H])C1C([H])=C([H])C(=C(C=1[H])O[H])O[H].O([H])[C@@]([H])(C(=O)O[H])[C@]([H])(C(=O)O[H])O[H]

InChi Key YLXIPWWIOISBDD-NDAAPVSOSA-N
InChi Code

InChI=1S/C9H13NO3.C4H6O6/c1-10-5-9(13)6-2-3-7(11)8(12)4-6;5-1(3(7)8)2(6)4(9)10/h2-4,9-13H,5H2,1H3;1-2,5-6H,(H,7,8)(H,9,10)/t9-;1-,2-/m01/s1
Chemical Name

(2R,3R)-2,3-dihydroxybutanedioic acid;4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol
Synonyms

Epitrate; l-Adrenaline bitartrate; Adrenalinium; L-Adrenaline tartrate; l-Epinephrine bitartrate; (-)-Adrenaline acid tartrate; (-)-Adrenaline bitartrate; (-)-Adrenaline hydrogen tartrate; (-)-Adrenaline tartrate; (-)-Epinephrine bitartrate; (R)-(-)-Epinephrine bitartrate; Epinephrine hydrogen tartrate; Epinephrine tartrate; l-Adrenaline hydrogen tartrate; (-)-Epinephrine (+)-bitartrate; l-Epinephrine d-bitartrate; l-Epinephrine tartrate; Medihaler-Epi; Primatene Mist Suspension; SuprareninAdrenaline acid tartrate; Adrenaline bitartrate; Adrenaline hydrogen tartrate; Asmatane Mist; Bronitin; Epinephrine bitartrate; l-Adrenaline d-bitartrate; Epinephrine d-bitartrate
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


Targets α2 adr; α2-adrenergic receptor; α-adrenergic receptor; β-adrenergic receptor
ln Vitro Dose and time response study on the effect of epinephrine on the Na+/K+-ATPase
Epinephrine (dissolved in ascorbic acid 0.5M) reduced in a dose and time-dependent manner the activity of the Na+/K+ ATPase in Caco-2 cells. The highest inhibitory effect was observed at 20 min and at a dose of 0.5 mM. Accordingly in all other experiments cell were treated with epinephrine for 20min and at a concentration of 0.5mM. Ascorbic acid alone exerted no significant effect on the activity of the pump.
Epinephrine acts via alpha-2 adrenergic receptors
The inhibitory effect of epinephrine on the Na+/K+-ATPase persisted when the cells were pre- incubated with of 0.03 mM propranolol (non selective β-adrenergic blocker) or 50 μM prazosin (selective α1 antagonist), but was no longer apparent in the presence of 0.1 mM yohimbine, a selective α2- adrenergic antagonist, suggesting that epinephrine exerts its effect by exclusively binding to its α2-adrenergic receptors.[2]
ln Vivo The present study examined the memory modulatory effect of epinephrine on latent learning of an inhibitory avoidance task. Male Sprague-Dawley rats on the first day were subjected to one of three conditions (no, short or long) in pre-exposure to the task apparatus. One day or several days later, they received the typical inhibitory avoidance training with a 0.5 mA/0.5 s foot shock. Memory of the inhibitory avoidance response was tested one day after the foot-shock training. The long pre-exposure group showed better memory than the no or short pre-exposure group, and this latent memory could last for 6 days: Retention scores of the long pre-exposure group were significantly better than those of the no pre-exposure group if the shock training was given 3 or 6 days, but not 12 or 21 days, after the pre-exposure. Epinephrine injected after the pre-exposure training modulated the latent memory in a dose- and time-dependent manner: 0.01 mg/kg given shortly after the short pre-exposure enhanced the memory, but 0.5 mg/kg given shortly after the long pre-exposure impaired it. Epinephrine injected 4 h after the pre-exposure had no effect, neither did that given to rats pre-exposed to a different context. Epinephrine (0.01 mg/kg) also made the latent memory lasting longer as the rats treated with it showed significant avoidance behavior when they had the shock training at 12 or 21 days after the pre-exposure. These findings suggest that epinephrine could modulate memory formed in the latent learning.[3]
Enzyme Assay Effect of epinephrine on the activity of the Na+/K+-ATPase Dose and time response studies were conducted. Caco-2 cells were treated with epinephrine for different time intervals (0; 10; 20; 45;75 min) and at different concentrations (0; 0.05; 0.2; 0.5; 0.8 mM). Epinephrine was dissolved in 0.5M ascorbic acid. The positive and negative control groups were incubated with and without ascorbic acid respectively.[2]
Cell Assay Cell culture of CaCo-2 cells CaCo-2 cells were used at passages 25–32. They were grown, at a density of 1200,000/well, on 100mm culture dishes in DMEM containing 4500 mg L-1 Glucose, sodium pyruvate, 1% Penicillin (100 μg mL-1), streptomycin (100 μg mL-1), 10% FBS, in a humidified incubator (95% O2, 5% CO2) at 37°C. Cells were always treated at 80–90% confluence.[2]
Animal Protocol Epinephrine in a 1 mg/ml solution and diluted by 0.9% saline to the appropriate concentrations for subcutaneous injections. For the immediate injection, rats were retrieved from the apparatus at the end of the pre-exposure phase and given the assigned injection before returning to their home cages. For the delayed injection, rats returned to their home cages after the pre-exposure training and received the drug 4 h later.[3]
References [1]. Am J Physiol. 1982 Apr;242(4):H593-601.
[2]. PLoS One. 2018; 13(2): e0193139.
[3]. Neurobiol Learn Mem. 2021 Jul:182:107447.
Additional Infomation Epinephrine Bitartrate is the bitartrate salt form of epinephrine, a direct-acting sympathomimetic amine with bronchodilator and vasoconstricting activity.
Epinephrine Bitartrate is the bitartrate salt form of epinephrine, a direct-acting sympathomimetic amine with bronchodilator and vasoconstricting activity. Epinephrine bitartrate acts on both alpha and beta adrenergic receptors. By stimulating alpha adrenergic receptors locally, this agent causes vasoconstriction and reduces vascular blood flow. Administered in the conjunctiva, epinephrine bitartrate induces vasoconstriction and decreases the production of aqueous humor mediated through alpha-adrenergic receptors. Through its beta-stimulating actions, this agent relaxes bronchial smooth muscle and causes bronchodilation.
The active sympathomimetic hormone from the ADRENAL MEDULLA. It stimulates both the alpha- and beta- adrenergic systems, causes systemic VASOCONSTRICTION and gastrointestinal relaxation, stimulates the HEART, and dilates BRONCHI and cerebral vessels. It is used in ASTHMA and CARDIAC FAILURE and to delay absorption of local ANESTHETICS.
See also: Epinephrine (has active moiety); Articaine Hydrochloride; Epinephrine Bitartrate (component of); Epinephrine Bitartrate; prilocaine hydrochloride (component of) ... View More ...

Solubility Data


Solubility (In Vitro)
DMSO: ~67 mg/mL (~201.0 mM)
Water: ~67 mg/mL (~201.0 mM)
Ethanol: <1 mg/mL
Solubility (In Vivo) N/A (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 3.0004 mL 15.0020 mL 30.0039 mL
5 mM 0.6001 mL 3.0004 mL 6.0008 mL
10 mM 0.3000 mL 1.5002 mL 3.0004 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.